Anti-TNF-a IBD Drugs Found to Not Be Associated with Cancer Risk

Anti-TNF-a IBD Drugs Found to Not Be Associated with Cancer Risk
A sigh of relief for many Chron’s and colitis patients: the class of drugs known as tumor necrosis factor alpha (TNF-a) antagonists do not cause an short-term increased risk of cancer. The findings originate from a study authored by Dr. Nynne Nyboe Andersen at the Statens Serum Institute in Copenhagen and published in the Journal

Knowledge is power when living with IBD.

Get access to the web’s leading IBD news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *